MindWalk Holdings (HYFT) FCF Margin (2023 - 2026)
MindWalk Holdings (HYFT) reported FCF Margin of 70.73% for Q1 2026, down 3074.0% year-over-year from 2.38% in Q1 2025, and up 100.0% quarter-over-quarter from 67798254.12% in Q4 2025.
MindWalk Holdings (HYFT) FCF Margin (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 4 years of FCF Margin data on file, last reported at 70.73% in Q1 2026.
- FCF Margin for Q1 2026 came in at 70.73%, down 3074.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 288.6% (down 22038.0% YoY), and the FY2025 annual result was 29400489.4%, down 2940047071.0% from the prior year.
- FCF Margin climbed to 70.73% in Q1 2026 per HYFT's latest filing, from 67798254.12% in the prior quarter.
- Over five years, FCF Margin peaked at 4.57% in Q4 2023 and troughed at 63081277800.24% in Q3 2024.
- A 4-year average of 4857634017.59% and a median of 81.34% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2025: FCF Margin tumbled 2000000000 bps in 2024, then jumped 2000000000 bps in 2025.
- A 4-year view of FCF Margin shows it stood at 4.57% in 2023, then plunged by 1880 bps to 81.34% in 2024, then slumped by 83355349 bps to 67798254.12% in 2025, then jumped by 100 bps to 70.73% in 2026.
- Business Quant data shows HYFT's FCF Margin at 70.73% in Q1 2026, 67798254.12% in Q4 2025, and 124359.38% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | -70.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -70.73% |
| Oct 31, 2025 | -67,798,254.12% |
| Jul 31, 2025 | -124,359.38% |
| Apr 30, 2025 | -34,078.21% |
| Jan 31, 2025 | -39.99% |
| Oct 31, 2024 | -81.34% |
| Jul 31, 2024 | -63,081,277,800.24% |
| Apr 30, 2024 | -50.29% |
| Jan 31, 2024 | -19.24% |
| Oct 31, 2023 | 4.57% |
| Jul 31, 2023 | -7,331.22% |
| Apr 30, 2023 | -84.72% |
| Jan 31, 2023 | -63.82% |